Skip to content
Lower risk Medical device recall · FDA · Published February 13, 2019

Randox BG50: Blood Gas Control pH Error Risk - Recall

Randox recalls BG5002 Blood Gas Control Level 2 due to pH range error in in-vitro diagnostics. This affects blood gas analysis quality control. No remedy specified in official notice.

🇺🇸 FDA recall #Z-1057-2019Medical deviceRandox ›
Take action

Contact the company

Recalling firmRandox Laboratories Ltd.55 Diamond Road · Crumlin (North), Ireland
✎ GovInfoNow plain-language explainer

Randox is recalling its BG5002 Blood Gas Control Level 2 product because of an error in the pH control range for blood gas analysis. This could lead to inaccurate test results if used in medical diagnostics. Read more at govinfonow.com/recall/69008-randox-bg50-blood-gas-control-ph-error-risk-recall.

Source Summary by GovInfoNow · govinfonow.com/recall/69008-randox-bg50-blood-gas-control-ph-error-risk-recall · Updated August 20, 2026 · FDA enforcement record: FDA #Z-1057-2019

Cite this page

“Randox BG50: Blood Gas Control pH Error Risk - Recall.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/69008-randox-bg50-blood-gas-control-ph-error-risk-recall. Based on FDA recall #Z-1057-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1057-2019%22&limit=1).

The FDA announced on Feb. 13, 2019, that Randox Laboratories Ltd. voluntarily recalled its Randox Blood Gas Control Level 2 (Model BG5002) due to an error in the assigned control range for pH. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Randox
  • Product: Randox Blood Gas Control Level 2 - Model BG5002
  • UPC: 05055273227116
  • Lot Code: 184BG

The hazard

The recall addresses an error in the assignment of the control range pH in Blood Gas Control, according to the FDA. The product is intended for in vitro diagnostic use in the quality control of blood gas analysis.

Context

GovInfoNow's records show Randox Laboratories Ltd. has 49 other recalls on record since June 7, 2017. Recent brand recalls include a Cystatin C Reagent recall on June 7, 2024, for missing FDA 510(k) clearance, an Evidence MultiSTAT Software v3.7 recall on April 5, 2024, involving light leak risks, and a Clinical Chemistry Calibration Serum recall on March 5, 2024, regarding inorganic phosphate bias. Other recent recalls of similar products include Siemens Epoc Blood Test Cards (April 2, 2026) and Abbott i-STAT EG6+ and G3+ Cartridges (April 1, 2026).

How to tell if you have this one

Check for the model number BG5002 on the product label. The lot code 184BG and GTIN 05055273227116 are specific identifiers for this recall.

  • Brand
    Randox
  • Product
    Randox Blood Gas Control Level 2 -Model BG5002. In-vitro Diagnostic Quality control of Blood Gas analysis This product
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the model number BG5002 and lot code 184BG on the product label.

Where it went and when

Where it was distributed

Distributed in West Virginia.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: yesWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “US Distribution to state of: WV” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: West Virginia.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Feb 13, 201912. FDA classified it Class II: Mar 26, 201923. Published in FDA’s Enforcement Report: Apr 3, 201934. FDA terminated the recall: Apr 14, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1057-2019 (February 13, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1057-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA